Mira
Pleasanton
About Mira
The first FDA and CE registered comprehensive women’s health monitoring platform with 99% of accuracy in clinical trials. Mira tracks cycles, predicts ovulation, monitors fetal health, measures ovarian reserve and detects menopause at home, with expandability into chronic disease monitoring, using the hospital-leveled technology within a palm-sized device. The data automatically syncs to the Mira app. The AI learns personal health patterns. The telemedicine connects users with doctors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: Less than $1M
- Total funding: $4.3M
- Last round: Series Unknown (Sep 2017)
- Website: miracare.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Fertility, Hardware, Health Care, Internet of Things
Social Profiles
Canonical: https://fsome.com/organization/mira-1515 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.